Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JENBURKT PH. vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JENBURKT PH. ZYDUS LIFESCIENCES JENBURKT PH./
ZYDUS LIFESCIENCES
 
P/E (TTM) x 12.8 21.6 59.2% View Chart
P/BV x 2.4 2.6 95.5% View Chart
Dividend Yield % 1.9 0.6 322.1%  

Financials

 JENBURKT PH.   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    JENBURKT PH.
Mar-22
ZYDUS LIFESCIENCES
Mar-22
JENBURKT PH./
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs700674 103.9%   
Low Rs391331 118.2%   
Sales per share (Unadj.) Rs270.1149.1 181.1%  
Earnings per share (Unadj.) Rs48.622.7 213.8%  
Cash flow per share (Unadj.) Rs52.729.7 177.6%  
Dividends per share (Unadj.) Rs12.002.50 480.0%  
Avg Dividend yield %2.20.5 442.1%  
Book value per share (Unadj.) Rs255.7166.1 154.0%  
Shares outstanding (eoy) m4.591,023.74 0.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.03.4 59.9%   
Avg P/E ratio x11.222.1 50.8%  
P/CF ratio (eoy) x10.316.9 61.1%  
Price / Book Value ratio x2.13.0 70.5%  
Dividend payout %24.711.0 224.5%   
Avg Mkt Cap Rs m2,503514,277 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m36521,777 1.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,240152,652 0.8%  
Other income Rs m492,354 2.1%   
Total revenues Rs m1,289155,006 0.8%   
Gross profit Rs m27334,427 0.8%  
Depreciation Rs m197,130 0.3%   
Interest Rs m41,270 0.3%   
Profit before tax Rs m29928,381 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m765,117 1.5%   
Profit after tax Rs m22323,264 1.0%  
Gross profit margin %22.022.6 97.5%  
Effective tax rate %25.418.0 140.6%   
Net profit margin %18.015.2 118.0%  
BALANCE SHEET DATA
Current assets Rs m759122,614 0.6%   
Current liabilities Rs m21378,394 0.3%   
Net working cap to sales %44.129.0 152.1%  
Current ratio x3.61.6 228.1%  
Inventory Days Days16293 174.9%  
Debtors Days Days44880 560.5%  
Net fixed assets Rs m667144,382 0.5%   
Share capital Rs m461,024 4.5%   
"Free" reserves Rs m1,128168,972 0.7%   
Net worth Rs m1,174169,996 0.7%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m1,426266,996 0.5%  
Interest coverage x69.823.3 299.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.6 152.1%   
Return on assets %15.99.2 173.5%  
Return on equity %19.013.7 138.8%  
Return on capital %25.817.1 151.2%  
Exports to sales %17.00-   
Imports to sales %014.3 0.0%   
Exports (fob) Rs m210NA-   
Imports (cif) Rs mNA21,869 0.0%   
Fx inflow Rs m21063,065 0.3%   
Fx outflow Rs m2821,869 0.1%   
Net fx Rs m18341,196 0.4%   
CASH FLOW
From Operations Rs m9421,041 0.4%  
From Investments Rs m-1311,544 -0.1%  
From Financial Activity Rs m-55-8,683 0.6%  
Net Cashflow Rs m2523,729 0.1%  

Share Holding

Indian Promoters % 46.0 75.0 61.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.5 16.2 21.5%  
FIIs % 3.5 2.5 139.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 54.0 25.0 215.9%  
Shareholders   5,784 370,396 1.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JENBURKT PH. With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    


More on JENBURKT PH. vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

JENBURKT PH. vs Cadila Healthcare Share Price Performance

Period JENBURKT PH. Cadila Healthcare S&P BSE HEALTHCARE
1-Day 1.02% 0.67% -0.34%
1-Month -1.38% 2.67% -2.09%
1-Year 6.54% 5.91% -6.69%
3-Year CAGR 14.91% 17.53% 17.24%
5-Year CAGR 2.23% 0.28% 9.09%

* Compound Annual Growth Rate

Here are more details on the JENBURKT PH. share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of JENBURKT PH. hold a 46.0% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of JENBURKT PH. and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, JENBURKT PH. paid a dividend of Rs 12.0 per share. This amounted to a Dividend Payout ratio of 24.7%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of JENBURKT PH., and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rebounds 400 Points from Day's Low | PSU Bank Stocks Rise Ahead of Union Budget 2023 | SBI Jumps 3% Sensex Today Rebounds 400 Points from Day's Low | PSU Bank Stocks Rise Ahead of Union Budget 2023 | SBI Jumps 3%(Closing)

After opening the day on a positive note, Indian share markets swung between gains and losses to trade on a volatile session throughout the day.